The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

Carcinoid tumors are part of a heterogeneous group of gastrointestinal and pancreatic endocrine tumors that are characterized by their capacity to produce and secrete hormones, 5-hydroxytryptamine ...

Some neuroendocrine tumours (NETs) make large amounts of hormones and proteins. The most common substance they make is serotonin. They sometimes release serotonin and the other proteins into the ...